Atlas Trials

Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients

Clinical trial NCT05626530 · RECRUITING

Trial details

NCT number
NCT05626530
Sponsor
Tufts Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Cytomegalovirus InfectionsInfection in Solid Organ Transplant RecipientsNeutropeniaAntiviral Toxicity
Start date
2023-02-02
Primary completion
2025-12-15
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.